These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19680720)

  • 1. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases.
    Cianni R; Urigo C; Notarianni E; Saltarelli A; Salvatori R; Pasqualini V; Dornbusch T; Cortesi E
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1179-86. PubMed ID: 19680720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
    Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
    J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
    Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases.
    Cianni R; Urigo C; Notarianni E; Saltarelli A; D'Agostini A; Iozzino M; Dornbusch T; Cortesi E
    Radiol Med; 2010 Jun; 115(4):619-33. PubMed ID: 20091135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.
    Memon K; Kuzel TM; Vouche M; Atassi R; Lewandowski RJ; Salem R
    Melanoma Res; 2014 Jun; 24(3):244-51. PubMed ID: 24638152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
    Stubbs RS; O'Brien I; Correia MM
    ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
    J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.
    Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M
    Intern Med J; 2005 Apr; 35(4):222-7. PubMed ID: 15836500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
    Kousik V; Promila P; Verma R; Gupta A
    Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Therasphere Radioembolization for Colorectal Metastases.
    Abbott AM; Kim R; Hoffe SE; Arslan B; Biebel B; Choi J; El-Haddad G; Kis B; Sweeney J; Meredith KL; Almhanna K; Strosberg J; Shibata D; Fulp WJ; Shridhar R
    Clin Colorectal Cancer; 2015 Sep; 14(3):146-53. PubMed ID: 25795047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
    Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP
    J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.
    Wong CY; Qing F; Savin M; Campbell J; Gates VL; Sherpa KM; Lewandowski RJ; Nagle C; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1101-6. PubMed ID: 16105922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
    Omed A; Lawrance JA; Murphy G; Laasch HU; Wilson G; Illidge T; Tipping J; Zivanovic M; Jeans S
    Clin Radiol; 2010 Sep; 65(9):720-8. PubMed ID: 20696299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
    Klingenstein A; Haug AR; Zech CJ; Schaller UC
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
    Sato KT; Lewandowski RJ; Mulcahy MF; Atassi B; Ryu RK; Gates VL; Nemcek AA; Barakat O; Benson A; Mandal R; Talamonti M; Wong CY; Miller FH; Newman SB; Shaw JM; Thurston KG; Omary RA; Salem R
    Radiology; 2008 May; 247(2):507-15. PubMed ID: 18349311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.
    Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M
    BMC Cancer; 2005 Oct; 5():132. PubMed ID: 16225697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.
    King J; Quinn R; Glenn DM; Janssen J; Tong D; Liaw W; Morris DL
    Cancer; 2008 Sep; 113(5):921-9. PubMed ID: 18618495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.